NCT07681440Terminated
A Study to Evaluate Luspatercept Utilization in Patients With Lower Risk Myelodysplastic Syndromes or Beta-thalassemia
Real World Use of Luspatercept in Lower Risk Myelodysplastic Syndromes and Beta-thalassemia Patients
Source: ClinicalTrials.gov · Last updated 2 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to understand the patient profile, utilized treatments, treatment patterns, resulting outcomes, and associated costs relating to luspatercept treatment in patients with lower-risk myelodysplastic syndromes (LR-MDS) or beta-thalassemia in the real-world setting
- Status (registry)
- Terminated
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 10 Oct 2025
- Start date
- 16 Nov 2023
- Primary completion date
- 1 May 2025
- Lead sponsor
- Bristol-Myers Squibb
- Diseases
- Myelodysplastic syndromes, Thalassaemia
- NCT number
- NCT07681440
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Participants treated with luspatercept. The date of first treatment with luspatercept will be assigned as the index date.
- At least one Lower-risk myelodysplastic syndromes (LR-MDS) or beta-thalassemia diagnosis in inpatient or at least two MDS or beta-thalassemia diagnosis in the outpatient setting at least 30 days apart prior to or at index date.
- 18+ years old at index date.
- Participants with a minimum of 12-months observable pre-treatment baseline/look-back prior to index date.
- Participants with a minimum of 6-months of follow-up time from the index date unless the patient is lost due to death
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ZEG Berlin, Center for Epidemiology and Health Research Coordinator of this site? Confirm its status | Berlin | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.